Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...
The U.S. agency in charge of nuclear security is commissioning a study on the proliferation risks of a more-enriched uranium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback